PharmEasy investor cuts value of its stake drastically, implying new valuation of $456M
PharmEasy's valuation has dropped significantly to approximately $456 million, as investor Janus Henderson values its shares at a fraction of the original investment.
MAIN POINTS
- PharmEasy's current valuation is approximately $456 million.
- Janus Henderson holds 12.9 million shares in PharmEasy.
- The asset manager's shares are now valued at $766,043.
- The initial investment by Janus Henderson was $9.4 million.
TAKEAWAYS
- PharmEasy's valuation has decreased by 92%.
- Janus Henderson's valuation reflects a significant loss on its investment.
- The drastic drop in valuation indicates potential challenges for PharmEasy.
- Investors may need to reassess their positions in PharmEasy.